BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38077915)

  • 1. Retracted: A Novel Necroptosis-Related lncRNA Signature for Osteosarcoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9812519. PubMed ID: 38077915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity.
    Liu B; Feng C; Liu Z; Tu C; Li Z
    Front Pharmacol; 2022; 13():944158. PubMed ID: 36105232
    [No Abstract]   [Full Text] [Related]  

  • 3. Retracted: Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9838096. PubMed ID: 38094385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma.
    International BR
    Biomed Res Int; 2022; 2022():9829634. PubMed ID: 36605105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
    International BR
    Biomed Res Int; 2024; 2024():9850107. PubMed ID: 38550181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Necroptosis-Related lncRNA Signature for Osteosarcoma.
    Zheng Y; Xu J; Lin J; Lin Y
    Comput Math Methods Med; 2022; 2022():8003525. PubMed ID: 35844445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients.
    Zhang GZ; Wu ZL; Li CY; Ren EH; Yuan WH; Deng YJ; Xie QQ
    Front Mol Biosci; 2021; 8():615084. PubMed ID: 34095215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
    Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
    Front Genet; 2022; 13():938250. PubMed ID: 36561319
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer.
    He WP; Chen YY; Wu LX; Guo YY; You ZS; Yang GF
    Front Immunol; 2022; 13():1018544. PubMed ID: 36466815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retracted] STK39, overexpressed in osteosarcoma, regulates osteosarcoma cell invasion and proliferation.
    Huang T; Zhou Y; Cao Y; Tao J; Zhou ZH; Hang DH
    Oncol Lett; 2024 Aug; 28(2):377. PubMed ID: 38939622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
    Front Genet; 2022; 13():862741. PubMed ID: 35368663
    [No Abstract]   [Full Text] [Related]  

  • 12. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
    Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H
    BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9894384. PubMed ID: 37810563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and validation model of necroptosis-related gene signature associates with immunity for osteosarcoma patients.
    Hua L; Lei P; Hu Y
    Sci Rep; 2022 Sep; 12(1):15893. PubMed ID: 36151259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer.
    Luo J; Peng J; Xiao W; Huang S; Cao Y; Wang T; Wang X
    Front Genet; 2022; 13():984696. PubMed ID: 36092933
    [No Abstract]   [Full Text] [Related]  

  • 16. Retracted: Identification of Atrial Fibrillation-Related lncRNA Based on Bioinformatic Analysis.
    Markers D
    Dis Markers; 2023; 2023():9783687. PubMed ID: 37564095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer.
    Sun YF; Chen L; Xia QJ; Wang TH
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10217-10234. PubMed ID: 37269345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Verification of Ferroptosis Subcluster-Associated Genes Related to Osteosarcoma and Exploration of Immune Targeted Therapy.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9768692. PubMed ID: 38189014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Analysing a Novel RNA-Binding-Protein-Related Prognostic Signature Highly Expressed in Breast Cancer.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9792854. PubMed ID: 37829426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Identification of Ferroptosis-Related Long Noncoding RNA and Construction of a Novel Prognostic Signature for Gastric Cancer.
    Markers D
    Dis Markers; 2023; 2023():9810178. PubMed ID: 37387742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.